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ABSTRACT 
 
Objective. To characterize the influence of diet on abdominal symptoms, anal gas 
evacuation, intestinal gas distribution and colonic microbiota in patients complaining of 
flatulence. Design. Patients complaining of flatulence (n=30) and healthy subjects (n=20) 
were instructed to follow their usual diet for 3 days (basal phase), and to consume a high-
flatulogenic diet for another 3 days (challenge phase). Results. During basal phase 
patients recorded more abdominal symptoms than healthy subjects in daily questionnaires 
(5.8±0.3 vs 0.4±0.2 mean discomfort/pain score, respectively; p=<0.0001), and more gas 
evacuations by an event marker (21.9±2.8 vs 7.4±1.0 daytime evacuations, respectively; 
p=0.0001), without differences in the volume of gas evacuated after a standard meal 
(262±22 and 265±25 mL, respectively). On flatulogenic diet, both groups recorded more 
abdominal symptoms (7.9±0.3 and 2.8±0.4 discomfort/pain, respectively), number of gas 
evacuations (44.4±5.3 and 21.7±2.9 daytime evacuations, respectively), and had more gas 
production (656±52 and 673±78 mL, respectively; p<0.05 vs basal diet for all). When 
challenged with flatulogenic diet, patients’ microbiota developed instability in composition, 
exhibiting variations in the main phyla and reduction of microbial diversity, whereas healthy 
subjects’ microbiota were stable. Taxa from Bacteroides fragilis or Bilophila wadsworthia 
correlated with number of gas evacuations or volume of gas evacuated, respectively. 
Conclusion. Patients complaining of flatulence have a poor tolerance of intestinal gas, 
which is associated with instability of the microbial ecosystem. 
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SUMMARY BOX 
 
 
What is already known about this subject?  
• Some patients specifically complain of excessive evacuation of gas per anus 
• Intestinal gas content depends by-and-large on gas production by bacterial 
fermentation of unabsorbed substrates  
• Diet influences anal gas evacuation and gut microbial composition 
 
What are the new findings? 
• A proportion of patients complaining of flatulence have increased number of gas 
evacuations, but net volume of gas evacuated is within the normal range  
• Flatulence is associated with abdominal symptoms 
• Patients’ microbiota present dysbiotic traits and characteristically respond with 
instability in microbial composition when consuming a flatulogenic diet 
• A number of gut bacterial taxa correlate with anal gas evacuations and volume of 
gas evacuated  
 
How might it impact on clinical practice in the foreseeable future?  
• Diet influences flatulence, abdominal symptoms, digestive comfort and stability of 
the gut microbial ecosystem in patients complaining of flatulence 
• Microbial biomarkers may predict symptoms associated with flatulence 
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INTRODUCTION 
  
Some patients complain of excessive evacuation of gas per anus, which may 
become socially disabling. However, the physiology and pathophysiology of flatulence 
remains poorly understood (1;2). 
Gas evacuated per anus originates by-and-large in the colon, where unabsorbed 
meal residues are fermented by colonic bacteria (3-5). However, even on the same diet, 
the amount of gas production exhibits very large interindividual differences. Hence, the 
volume of gas produced and evacuated per anus is determined by two main factors: the 
diet, particularly the amount of fermentable residues, and the composition and metabolic 
activity of colonic microbiota.  
We hypothesized that patients complaining of excessive passage of gas per anus: a) 
really have higher number of gas evacuations on their usual diet than healthy subjects; b) 
have more intestinal gas production and evacuate more volume of gas; c) gas evacuation 
depends on diet, but the differences in number of evacuations and volume of gas 
evacuated between patients and healthy subject are not due to differences in diet, i.e., are 
also present on a standardized diet; d) these differences are associated to differences in 
the colonic microbiota. Hence, our aims were to determine: a) the effect of diet on the 
number of gas evacuations and the volume of gas evacuated; b) whether the number of 
evacuations and the gas volume evacuated is increased in patients complaining of 
flatulence; and c) the relationships between diet, abdominal sensations, gas evacuation 
and colonic microbiota. To this aim, we designed a comprehensive study comparing 
patients complaining of excessive passage of gas per anus and healthy subjects. We took 
advantage of high-throughput sequencing technology and recently developed bioinformatic 
tools to comprehensively analyze the whole spectrum of gut microbial communities.  
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MATERIAL AND METHODS 
 
Participants  
Thirty patients complaining of excessive passage of gas per anus (age range 25-65 
years), and 20 healthy subjects without gastrointestinal symptoms (age range 21-63 years) 
participated in the study. Antibiotic consumption during the previous 2 months was an 
exclusion criterion. Patients who consulted for excessive passage of gas per anus were 
instructed to prospectively fill out a clinical questionnaire (see details in clinical 
questionnaire below) for 3 days (entry period), and only those scoring anal gas evacuation 
≥5 on a 10 point scale were offered to participate in the study. All patients reported 
associated symptoms and fulfilled Rome III criteria for either postprandial distress 
syndrome (n=15), irritable bowel syndrome (IBS; n=11; 5 diarrhoea-predominant, 2 
constipation-predominant and 4 alternating) or functional abdominal pain (n=4) (6;7). In 
healthy subjects the same evaluation was performed during the entry period, to confirm the 
absence of gastrointestinal symptoms. Subjects gave written informed consent to 
participate in the study. The protocol for the study was previously approved by the 
Institutional Review Board of University Hospital Vall d´Hebron.  
 
Study design 
Participants were instructed to follow their usual diet for 3 days (basal phase), and  
to consume a diet rich in fermentable residues for another three days (challenge phase), 
during which, each meal (breakfast, lunch, dinner) included at least on portion of the 
following: a) bread, cereals and pastries made of whole wheat or corn; b) beans, soya 
bean, corn, broad bean, peas; c) Brussels’ sprouts, cauliflower, broccoli, cabbage,  celery, 
onion, leek, garlic, artichoke; and d) banana, fig, peach, grapes, prunes. A specifically 
trained nurse provided detailed instructions about the foods to be consumed, but the caloric 
content of the diet was not standardized. Participants were offered to obtain the foodstuffs 
directly in the research unit. To address compliance to the diet, participants were instructed 
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to fill out a diary specifying the foods consumed.  
During both dietary intervention phases the following evaluations were performed: a) 
clinical data; b) number of anal gas evacuations; c) microbiota analysis (stool sampling last 
2 days); in the morning of the 4th day d) volume of intestinal gas produced after a test meal, 
and e) volume of abdominal gas by CT imaging after the challenge phase in patients only.  
 
Measurements 
Number of anal gas evacuations  
The number of gas evacuations per anus was measured using an event marker 
(DT2000 Memory Stopwatch, Digi sport instruments, Shanggiu, China) during each study 
phase. Participants were instructed to carry the event marker during daytime and to register 
every evacuation of gas per anus. Previous studies measuring the number of gas 
evacuations simultaneously by and event marker and continuous recording of anal gas 
evacuation showed a very good correlation (8-11). 
  
Clinical data 
Participants were instructed to fill-out at the end of the 3 days during each study 
phase a questionnaire that evaluated the following parameters: a) number of bowel 
movements and stool form using the Bristol scale (12); b) subjective sensations of 
flatulence (defined as anal gas evacuation), abdominal bloating (pressure/fullness), 
abdominal distension (girth increment), borborygmi, and abdominal discomfort/pain, by 
corresponding 0-10 analogue scales; and c) digestive well-being using a 10 point scale 
graded from +5 (satisfaction) to -5 (dissatisfaction). The last day of each study phase, body 
weight and girth were measured. 
 
Volume of intestinal gas produced after a test meal 
Gas collection tests were conducted after overnight fast the 4th day of each study 
phase.  A standard meal (either normal or flatulogenic) was administered and the volume of 
 Azpiroz    7 
 
gas evacuated was measured for 6 h, as previously described (13;14); in brief, gas was 
collected using a rectal balloon catheter (20 F Foley catheter, Bard, Barcelona, Spain) 
connected via a line without leaks to a barostat, and the volume was continuously 
recorded. The normal meal was administered at the end of the basal phase and consisted 
in a glass of milk (coffee optional) and  buttered toasts with marmalade (330 Kcal, 1.2 g 
fibre); the flatulogenic meal was administered at the end of the challenge phase and 
consisted in cooked beans with sausage, whole wheat bread and canned peach (874 Kcal, 
26.5 g fibre).  
 
Volume of abdominal gas 
Abdominal CT scans were obtained after the 6 h gas collection test with a helical 
multislice CT scanner (Mx8000, Philips Medical Systems, Best, The Netherlands) with the 
following specifications: exposure of 120 kV and 50 mAs, 2.5-mm section thickness, 
reconstruction at 1.6-mm intervals, 1.5 pitch ratio, and 512 x 512 acquisition matrix (15). 
With these characteristics the total effective dose was 2.4 mSv, similar to the dose of a CT 
colography and approximately ¼ of the dose of a standard CT scan (16). Abdominal gas 
volume was measured using a software program developed in our laboratory (15).  
 
Microbiota analysis 
A total of 100 fecal samples (basal and challenge phase in each participant) were 
used for microbial community analysis. Fecal samples were collected at home, kept 
immediately at -20ºC in the home freezer, and delivered frozen to the laboratory using a 
freezer pack. They were stored at -80ºC for later analysis. Subjects were instructed to 
collect fecal samples on the 2 days prior to their scheduled visit on the last day of each 
study phase and the last sample was used. Genomic DNA extraction was conducted as 
described by Godon et al (17). DNA was then submitted to PCR-amplification of the V4 
region of the bacterial and archaeal 16S rRNA gene. The V4 primer pairs used in this study 
are expected to amplify almost 100% of the Archaea and Bacteria domains according to 
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our analysis done using PrimerProspector software (18). The forward (V4F_517_17: 5’- 
GCCAGCAGCCGCGGTAA -3’) and reverse (V4R_805_19: 5’- 
GACTACCAGGGTATCTAAT -3’) primers targeting the 16S gene had their 5’ ends tagged 
with specific sequences for pyrosequencing as follows: 5’-
CCATCTCATCCCTGCGTGTCTCCGACTCAG-{MID}-{GCCAGCAGCCGCGGTAA}-3’ and 
5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG-{GACTACCAGGGTATCTAAT}-3’. Tag 
pyrosequencing was performed using multiplex identifiers (MIDs) of 10 bases provided by 
Roche, which were specified upstream the forward primer sequence (V4F_517_17). 
Standard PCR was run in a Mastercycler gradient (Eppendorf) at 94°C for 2 min, followed 
by 35 cycles of 94°C for 30 sec, 56°C for 20 sec, 72°C for 40 sec, and a final cycle of 72°C 
for 7 min. The 16S rRNA V4 amplicons were subsequently sequenced on the 454 Life 
Sciences (Roche) Genome Sequencer FLX and Junior platforms (Scientific and Technical 
Support Unit, Vall d’Hebron Research Institut, Barcelona, Spain), according to standard 
454 platform protocols. 
Pyrosequencing of the PCR products generated a total of 570,000 raw sequences 
from all the samples. These sequences (or reads) were subsequently filtered using version 
1.3 of the QIIME pipeline (19), following the recommendations of Huse et al (20). Cd-hit 
(21) was used to cluster sequences into OTUs (operational taxonomic unit, or taxa) at 97% 
sequence identity. We also compared this approach with the UCLUST (22) clustering 
method, with similar results in terms of diversity and OTU numbers. Representative 
sequences for each OTU were aligned using PyNAST (23) against Greengenes template 
alignment (February 2011 release) (24), and taxonomy was assigned to the OTUs detected 
using BLAST (25) and the Greengenes taxonomy mapping file. We considered only taxa 
that were represented in at least one sample by at least 0.2% of the sequences in that 
sample. 
 
Statistical analysis 
Microbiota analysis 
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For alpha and beta microbiota diversity analysis, samples were sub-sampled to 1356 
sequences per sample to remove biases due to sequencing depth. Rarefied at 1356 
sequences per sample, all samples in our dataset had an average of Good’s coverage of 
97% (SD +/- 0.84), which means that at this level of coverage an additional sequence 
would have only a 3% chance of belonging to a previously unseen type. Distance matrices 
were built based using both the weighted and unweighted UniFrac metrics, and hierarchical 
clustering with UPGMA (unweighted pair group method with arithmetic mean) was used to 
build trees.  
 
Overall comparisons 
In each subject, daily measurements during each diet were averaged. In each group 
of subjects, mean or grand mean values (±SE) of all parameters measured were 
calculated. Overall comparison of each variable between data sets (patients and healthy 
subjects, before and after diet challenge) was performed by Kruskal-Wallis non-parametric 
ANOVA, and if variation among data sets was considered significant (p<0.05), post hoc 
comparisons between data sets were tested by Dunn’s multiple comparisons method. 
Correlations of paired data were analyzed by linear regression analysis. Prevalence of 
specific microbial groups among individuals was compared by Chi-squared test for 
independence (overall comparison) and the Fisher exact test (two groups comparison). 
 
 
RESULTS  
 
Basal phase 
The caloric content of the diet during the basal period was similar in patients 
(1584±58 kcal/d) and healthy subjects (1582±51 kcal/d), but the fibre content was lower in 
patients (13.3±0.9 g/d vs 17.7±0.7 g/d in healthy subjects; p=0.003). 
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Number of gas evacuations 
On their current diet healthy subjects evacuated gas per anus a mean of 7.4±1.0 
times during daytime (Figure 1). The number of gas evacuations was significantly higher in 
patients complaining of flatulence (21.9±2.8 evacuations during daytime, p>0.001 vs 
health), but in 18 of them the number of evacuations was within the normal range (< 18 
evacuations during daytime) (Figure 1).  
 
Clinical parameters 
On their basal diet healthy subjects experienced virtually no abdominal symptoms, 
and interestingly, reported a relatively high level of digestive comfort (Figure 2). In patients, 
subjective perception of flatulence was higher than in healthy subjects but interestingly, 
they also reported abdominal symptoms and negative gut comfort (Figure 2). In patients 
with abnormal number of gas evacuations, flatulence sensation was higher than in those 
within the normal range (8.3±0.3 score vs 6.7±0.3 score; p<0.001); but overall the 
correlation of sensation of subjective flatulence and objective number of evacuations was 
only modest (R=0.64; p<0.001). The severity of other clinical symptoms, including digestive 
well-being, was not related to the number of evacuations and flatulence sensation. No 
differences in stool form and frequency were detected between patients (4.2±0.3 Bristol 
score, 1.8±0.2 daily stools) and healthy subjects (4.2±0.2 Bristol score, 1.4±0.1 daily 
stools). 
 
Volume of gas evacuation 
After a normal breakfast, healthy subjects evacuated a mean volume of 269±24 mL 
gas in 6 hours (Figure 3 and Supplemental figure S1). Patients evacuated a similar volume 
of gas after the standard breakfast (262±22 mL; p=0.943 vs health) (Figure 3), despite the 
higher number of gas evacuations measured in the previous days; the correlation of both 
parameters (volume evacuated vs number of evacuations in previous days) was poor 
(R=0.36; p=0.048). The evacuation rate decreased 5 h after breakfast in both groups 
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(Figure 3).  
 
Microbial profiles 
The phylogenetic characterization of samples from healthy subjects uncovered four 
main bacterial phyla in the following proportions: Firmicutes (50%), Bacteroidetes (46%), 
Actinobacteria (1.3%) and Proteobacteria (2.3%). Archaebacteria, and less abundant 
bacterial phyla such as Fusobacteria, RF3, Tenericutes and Lentisphaerae, were also 
present. Across all taxa, 61 genera and 547 OTUs, with an average of 131 observed OTUs 
per sample were identified. The genera that accounted for 61% of the sequences were: 
Bacteroides (22%), Prevotella (18%), Faecalibacterium (8%), unknown Lachnospiraceae 
(7%) and unknown Ruminococcaceae (6.2%). At the species level, an unknown Prevotella 
(14.6%), Bacteroides uniformis (6%), Bacteroides plebeius (5.6%), two unknown 
Faecalibacterium (7.1%) and an unknown Roseburia (3.6%) represented the most 
abundant taxa (37%). Methanobrevibacter smithii was detected as the sole representative 
of Archaea. 
Weighted UniFrac-based principal coordinates analysis (PCoA) did not segregate 
patient and healthy subject samples into different clusters (Supplemental figure S2A), 
suggesting that microbiota of patients and healthy subjects were similar in terms of 
proportion of the main taxonomic phyla (Supplemental figure S2B), richness (Chao1 
estimation; Supplemental figure S3A) and average number of taxa per individual (131 for 
healthy subjects and 130 for patients; Supplemental figure S3B). However, differences 
between patients and healthy subjects involved less abundant microbial groups or taxa. 
Thus, nine bacterial taxa, which accounted for 4.9% of the overall sequence dataset, were 
significantly higher (from 2 to 20-fold; p < 0.05) in patients than in healthy subjects. These 
nine taxa belonged to Bacteroidetes, Firmicutes and Actinobacteria phyla and fell within six 
genera: Clostridium, Phascolarctobacterium, Bacteroides, Coprococcus, Blautia and an 
uncultured Bifidobacteriales (Supplemental table S1). In addition, seven unknown bacterial 
taxa were found to be significantly under-represented in patients (2 to 24-fold lower; p < 
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0.05) relative to the healthy group. These taxa belong to five genera: Bacteroides, 
Oscillospira, uncultured Ruminococcaceae, uncultured Bacteroidales and uncultured 
Clostridiales.  
 
Challenge phase 
The fibre content of the challenge diet was significantly higher than the basal diet 
both in patients and health subjects (26.3±0.9 g/d and 28.1±1.9 g/d, respectively; p<0.001 
vs basal for both), but the caloric content remained similar (1494±37 kcal/d and 1500±63 
kcal/d, respectively).  
 
Number of gas evacuations 
The flatulogenic diet effectively increased the number of gas evacuations both in 
healthy subjects and in patients (0.6±0.1 evacuations/h in healthy subjects and 1.3± 0.1 in 
patients; p<0.048 vs basal for both). The net effect of the diet was similar in both groups 
(Figure 1). The number of gas evacuations on the challenge diet correlated with that on the 
basal diet (R=0.851; p<0.001).  
 
Clinical parameters 
The flatulogenic diet was associated with a significant increase in body weight and 
girth in healthy subjects ( by 780±100 g and 13.0±0.2 mm, respectively; p<0.001 for both) 
and in patients (by 900±400 g; p=0.020 ; and 14.0±0.2 mm; p<0.001; respectively; N.S. vs 
health). Healthy subjects experienced abdominal symptoms on the flatulogenic diet and 
reported a decrease in digestive comfort (Figure 2). Their symptom profile during the 
challenge diet became similar to that of patients at baseline. In patients on the challenge 
diet, abdominal symptoms significantly worsened, and the level of digestive well-being in 
the comfort/discomfort scale further deteriorated (Figure 2). In healthy subjects, with low 
basal scores, the effect on symptoms became clear after the first day of diet and increased 
over the following 2 days of diet. In patients the effect of diet on symptom was significant, 
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but limited (less marked than in healthy subjects) because basal scores were already at the 
top of the scales with small span for worsening (Figure 2). Diet did not influence stool 
frequency and consistency in either patients or healthy subjects (data not shown). 
 
Volume of gas evacuation 
The volume of gas evacuated after the flatulogenic test meal was significantly higher 
than that measured during the basal phase in patients and healthy subjects alike (656±52 
mL and 673±78 mL, respectively; p<0.001 vs basal for both) (Figure 3), but the relation of 
both volumes (basal vs flatulogenic diet) was poor (R = 0.477; p = 0.001; pooling patients 
and healthy subjects; Supplemental figure S1). As during the basal diet, the correlation of 
the volume evacuated and the number of gas evacuations measured the days before was 
poor (R=0.10; p=0.235; pooling patients and healthy subjects). 
 
Intestinal gas distribution  
Total abdominal gas volume in patients was 167±19 mL with 29±6 mL in the 
stomach, 24±7 mL in the small bowel and 113±17 mL in the colon (28±4 mL right, 28±10 
mL transverse, 32±9 mL left and 25±5 mL pelvic colon). No significant differences in total or 
segmental colonic gas volumes were observed either between patients with a number of 
gas evacuations within versus above the normal range during the basal phase or between 
the half of patients with higher versus the half with lower volume of gas evacuated after the 
test meal (data not shown).  
 
Microbial profiles 
In samples obtained after the flatulogenic diet, the unweighted and weighted 
UniFrac-PCoA analysis did not detect dysbiosis (Supplemental figure S2A). However, both 
a reduction of the Chao1 estimator and the number of observed taxa (paired t test, p = 
0.004 and p = 0.007, respectively) indicated an overall lower microbial richness after 
flatulogenic diet than during the basal phase in patients (Supplemental figure S3A and S3B, 
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respectively), but not in healthy subjects. In addition to this diet-related reduction of 
microbial diversity in patients, UPGMA clustering of weighted UniFrac distances revealed 
that the microbial community of patients was less stable than that of healthy subjects when 
challenged by the flatulogenic diet, as revealed by wider distance between basal and 
challenge microbiota (branch length of 0.056 for patients vs 0.043 for healthy controls). 
Taxonomic analysis showed that flatulogenic diet did not change the average proportion of 
the main bacterial phyla in controls’ and patients’ microbiota (Supplemental figure S2B). 
However, when analyzed individually, taxonomic analysis showed that the diet had a strong 
impact on the patients’ microbial composition (Figure 4) depicting a higher fluctuation 
among patients’ samples compared to controls. In comparison to healthy controls, patients 
changed significantly more in representation of the two main bacterial phyla: Bacteroidetes 
(p = 0.0007) and Firmicutes (p = 0.001).  
 
 
Relation of clinical features and physiological parameters 
No differences between patients with more (n=12) versus those with less (n=18) 
than 18 evacuations per day during basal conditions (upper limit of normal range) were 
found during basal phase in caloric and fibre content of the diet, abdominal symptoms, 
volume of gas evacuated, and microbial profiles (data not shown). Physiological 
parameters were compared among subgroups of patients fulfilling criteria for postprandial 
distress syndrome, IBS and functional abdominal pain, and no consistent differences in 
number of gas evacuations, volume of gas evacuated after the test meal, volume of colonic 
gas measured in the CT scans and microbiota profile were found either during the basal 
phase or in response to the challenge diet (variations normalised with baseline). 
By contrast, several associations between bacterial taxa and symptoms were found. 
At baseline, three taxa positively correlated (Pearson correlation, from R = 0.56 to R = 0.71; 
p < 0.0001; FDR < 0.01) with number of gas evacuations: Bacteroides uniformis, 
Bacteroides ovatus and Parabacteoides distasonis. Another taxon, Bilophila wadsworthia, 
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positively correlated with volume of gas evacuated (R = 0.64; p < 0.001; FDR = 0.12). An 
unknown Lachnospiraceae taxon, which was prevalent in all subjects, was negatively 
correlated with abdominal pain (R = -0.57; p < 0.001; FDR = 0.19). Finally, after the diet 
challenge, one bacterial taxon (another unknown Lachnospiraceae) was positively 
correlated with the occurrence of borborygmi (R = 0.57; p < 0.002; FDR = 0.08). 
 
 
DISCUSSION 
Our data indicate, first, that flatulence is associated to other abdominal symptoms 
and loss of digestive comfort, second, that the net volume of gas produced by flatulent 
patients after a standard meal is within the normal range, third, that diet influences gas 
production and flatulence as well as abdominal symptoms and digestive comfort in healthy 
subjects and more so in flatulent patients, and fourth that there are differences in 
composition and stability of the gut microbial ecosystem between patients with flatulence 
and healthy subjects. 
It has been shown that some food components in the normal diet, such as resistant 
starch, oligosaccharides and plant fibres, are incompletely absorbed in the small bowel and 
enter the colon (3-5;26-28). The colon harbours large amount of bacteria that may ferment 
these products releasing hydrogen and carbon dioxide (29-31). However, other pools of 
colonic microorganisms, particularly sulphate-reducing bacteria, acetogenic bacteria, and 
methanogenic archaea, consume a large proportion of the gases produced by 
fermentation. Hypothetically, profiling the whole spectrum of resident colonic bacteria may 
help in understanding differences in gas metabolism and evacuation between individuals. 
We selected a population of patients whose predominant complaint was flatulence. 
However, this subjective perception was not objective in a portion of them, and despite their 
belief, their number of gas evacuations was within the normal range. On the other hand, 
when specifically questioned, it became clear that flatulence was associated in most 
instances with other symptoms, particularly abdominal bloating. Interestingly, the volume of 
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gas produced after a test meal by flatulent patients, either with number of evacuations 
within or above the normal range, was not increased as compared with healthy subjects. 
Given the almost identical volume evacuated over 6 hours after a meal, the difference in 
number of gas evacuations cannot be secondary to the net amount of gas produced. The 
obvious possibilities included increased sensitivity and/or reduced compliance of the distal 
colon and rectum. The alternative possibility of gas being retained within the colon after the 
test meal was ruled out by careful volumetric analysis of intestinal gas volume based on CT 
imaging.  
Rectal sensitivity was not evaluated in these patients, but previous studies 
consistently found gut hypersensitivity in patients with functional gut disorders and 
abdominal bloating (32;33). Rectal compliance in patients with functional gut disorders is 
related to bowel habit; lower compliance has been shown in those with diarrhoea (32;33). 
Differences in gut microbiota between patients and healthy subjects may not only explain 
changes in net gas production, but theoretically could also affect gut function, including 
sensitivity and tonic motor activity, i.e., compliance (34). Indeed, gas evacuation frequency 
was positively correlated with three bacterial taxa (Bacteroides uniformis, Bacteroides 
ovatus and Parabacteroides distasonis). Among these, Bacteroides ovatus was found in 
significantly higher abundance in patients. Remarkably, these three co-occurring taxa of the 
Bacteroides fragilis group had been found also associated in other studies and to be 
producers of an enterotoxin (35-37). Bacteroides ovatus in particular has been associated 
with a systemic antibody response in inflammatory bowel disease (38) and with alterations 
to epithelial integrity in animal models of chronic intestinal inflammation (39). These species 
could trigger inflammatory pathways leading to hypersensitivity and poor tolerance of 
intestinal gas.  
Our data on the effect of diet on gas evacuation obtained with a thorough 
methodology in a fairly large population of healthy subjects confirms previous observations 
(40-41). The effect of the high flatulogenic diet in patients was similar as in healthy 
subjects, both the number of anal gas evacuations, as well as the volume of gas 
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evacuated, consistently increased. Diet increased not only gas production and evacuation, 
but also the severity of associated symptoms, and reduced digestive comfort. The 
deleterious effect of fibre on irritable bowel symptoms has been previously described (42). 
Interestingly, the high flatulogenic diet in healthy subjects induced symptoms similar to 
those reported by patients during basal conditions. The mechanism by which diet 
influenced symptoms seems likely related to the increment in gas production. Furthermore, 
the flatulogenic high-residue diet conceivably increased intestinal content, and this may 
explain the increase in body weight.  
The taxonomic information presented by the cohort of patients and healthy subjects 
enrolled in our study is consistent with previous reports in terms of similarity of microbial 
structure from the phylum to the genus level (43-45). However, at species level, patients 
showed clear dysbiotic traits. Nine bacterial taxa (5% of the sequences dataset, belonging 
to Clostridium, Phascolarctobacterium, Bacteroides, Coprococcus, Blautia and an 
uncultured Bifidobacteriales) were more abundant in patients than in healthy subjects, and 
seven unknown bacterial taxa (belonging to Bacteroides, Oscillospira, uncultured 
Ruminococcaceae, uncultured Bacteroidales and uncultured Clostridiales) were found to be 
under-represented in patients. Moreover, in contrast to healthy controls, the flatulogenic 
diet revealed an unstable microbial community in patients complaining of flatulence, with 
dramatic changes at the phylum level. Those microbial changes were temporarily linked 
with worsening of symptoms, and a remarkable increase in gas evacuations. The volume of 
gas evacuated was positively correlated with Bilophila wadsworthia, a known opportunistic 
gut pathogen found in numerous anaerobic infections (46, 47). Bilophila wadsworthia, a 
delta-proteobacteria, could be directly involved in the production of gas; this species is a 
saccharolytic bacteria that can reduce nitrate to nitrite and occasionally to N2, and is also 
characterized by a strong catalase activity and production of hydrogen sulfide from sulfur-
containing amino acids (47). 
Our data may help to improve management of patients complaining of flatulence. 
The diagnosis of these patients should include a systematic evaluation of associated 
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abdominal symptoms and their impact on digestive well-being. Specific challenge diets may 
allow the patients to identify the most offending foodstuffs. Low robustness of the 
microbiota in response to dietary challenges seems to be a crucial defect in patients 
complaining of flatulence. The potential role of microbiota on gut function and food 
tolerance may open future treatment strategies that may be more practical than restrictive 
diets for long-range adherence. 
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FIGURE LEGENDS  
 
 
Figure 1. Effect of diet on the number of daytime anal gas evacuations. Note higher 
number in patients than in healthy subjects both during basal (B) and 
challenge diet (C), and marked increase during challenge diet. Data are 
individual values (average of 3 daily measurements during basal phase and 
last 2 days challenge phase). Doted line represents upper limit of normal 
range during basal diet. 
 
Figure 2. Effect of diet on clinical parameters. Symptoms (scored from 0 to 10) and 
digestive comfort (scored from +5 to - 5) the last day of basal and challenge 
phases. Data are means ±SE.  
 
Figure 3. Postprandial rectal gas collection. Cumulative data (means±SE) after test 
meal.  
 
Figure 4.  Changes in microbiota at taxonomy level after challenge diet. A. For each 
individual (20 healthy subjects and 29 patients) the abundance of  Firmicutes 
(in blue) and Bacteroidetes (in red) during basal (●) and challenge phase 
(▲) is shown (connected by line). B. Variations from baseline induced by 
challenge diet of the four most abundant bacterial phyla (individual data and 
mean values are shown).  
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